Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-PSMA”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04186845
What this trial is testing

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 391
Very early researchStudy completedNCT05725070
What this trial is testing

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
ARTBIO Inc. 3
Not applicableUnknownNCT03876912
What this trial is testing

The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Turku University Hospital 35
Very early researchLooking for participantsNCT06756334
What this trial is testing

Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 30
Early research (Phase 1)Study completedNCT03558711
What this trial is testing

PSMA-PET/CT for Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Ghent 6
Not applicableStudy completedNCT04986280
What this trial is testing

Diagnostic Accuracy and Performance of 18F-PSMA-1007

Who this might be right for
Prostate Cancer
Insel Gruppe AG, University Hospital Bern 174
Post-approval studies (Phase 4)WithdrawnNCT05568537
What this trial is testing

Prostate MRI and Pylarify PSMA PET/CT

Who this might be right for
Prostate Cancer
Corewell Health East
Testing effectiveness (Phase 2)Study completedNCT03573011
What this trial is testing

PSMA PET/CT for Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Ghent 64
Very early researchUnknownNCT06462508
What this trial is testing

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 30
Not applicableStudy completedNCT03535831
What this trial is testing

PSMA PET Registry (18F-DCFPyL)

Who this might be right for
Carcinoma of Prostate
University Health Network, Toronto 142
Early research (Phase 1)Study completedNCT02151760
What this trial is testing

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Testing effectiveness (Phase 2)Study completedNCT04775602
What this trial is testing

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.

Who this might be right for
18F-PSMAProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 550
Not applicableStudy completedNCT03718260
What this trial is testing

PSMA-PET Registry for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 9,684
Testing effectiveness (Phase 2)WithdrawnNCT04910425
What this trial is testing

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Who this might be right for
Prostate Carcinoma
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT06305390
What this trial is testing

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

Who this might be right for
Clinical Suspicion of Prostate Cancer
IRCCS San Raffaele 167
Early research (Phase 1)Study completedNCT03793543
What this trial is testing

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)WithdrawnNCT03800784
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03860987
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Who this might be right for
Castrate Sensitive Prostate Cancer
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT06167629
What this trial is testing

Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Early research (Phase 1)Study completedNCT02916537
What this trial is testing

Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation